The NASDAQ Biotech Stock to Watch in 2022

Positive Phase 1 Data Has Just Been Released as This Emerging Company Aims to Succeed in the Massive TNF Blocker Market that Has Made Humira Nearly $20B!

Teamed with industry leaders in science, this emerging biotech company is targeting age related diseases as well as auto-immune, chronic pain, and anxiety and sleep disorders. The company has partnered with academic founders and key opinion leaders to identify synthetic therapeutics, including the very first drug the company is aware of that is being designed to significantly delay aging!

The company recently released Phase 1 clinical trial data that demonstrates their drug had a reduction of tumor necrosis factor-alpha (TNF-α) in the blood of healthy HUMAN subjects. In other words. Phase-1 dose-ranging study results meet primary endpoints, and the drug demonstrates statistically significant efficacy in reducing TNF-α in the blood! Why is this so significant? TNF-α are the molecules that are the root cause of aging!

According to the company, there are NO FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be $600 billion by 2025.

See how this company's drug platforms are seeking to become best-in-class treatments for some of the most notorious diseases and disorders!

DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.

UpTrendAlerts, 711 SW 24th Ave, Boynton Beach, FL 33435, United States You may unsubscribe or change your contact details at any time. Powered by: